Clinical trial
Safety Study of Oral Edaravone Administered in Subjects With ALS
NCT04165824 is registered in ClinicalTrials.gov with Shionogi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety Study of Oral Edaravone Administered in Subjects With ALS
- Lead sponsor
- Shionogi
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 18, 2019
- Completion date
- October 7, 2021
- Enrollment
- 185 (actual)
- Sites
- 53
Conditions
As the registry lists them; a condition with its own page is linked.
als